Dose-Escalated Total-Marrow Irradiation (TMI) for Relapsed Multiple Myeloma

International Journal of Radiation Oncology Biology Physics - Netherlands
doi 10.1016/j.ijrobp.2015.07.156
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Multicenter, Phase I, Dose-Escalation Trial of Lenalidomide Plus Bortezomib for Relapsed and Relapsed/Refractory Multiple Myeloma

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2009English

Carfilzomib for Relapsed or Refractory Multiple Myeloma

The Lancet Oncology
Oncology
2018English

Tanespimycin Monotherapy in Relapsed Multiple Myeloma: Results of a Phase 1 Dose-Escalation Study

British Journal of Haematology
Hematology
2010English

Bone Marrow Angiogenesis in Multiple Myeloma

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2005English

Total Marrow Irradiation Using Helical Tomotherapy

English

Ixazomib in the Treatment of Relapsed Multiple Myeloma

Medical Council
2018English

Prospective Assessment of Radiation Dose Toxicity Correlations in Patients Who Received Intensity Modulated Total Marrow Irradiation (IM-TMI) as Part of Conditioning Regimen Prior to Stem Cell Transplant

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2016English

Low-Dose Lenalidomide and Dexamethasone Combination Treatment in Elderly Patients With Relapsed and Refractory Multiple Myeloma

Hematology
Hematology
2016English

Bendamustine, Pomalidomide, and Dexamethasone for Relapsed and/or Refractory Multiple Myeloma

Blood Cancer Journal
OncologyHematology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy